Asio Capital LLC Cuts Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Asio Capital LLC lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 17,361 shares of the company’s stock after selling 123 shares during the period. HCA Healthcare comprises approximately 1.3% of Asio Capital LLC’s investment portfolio, making the stock its 20th biggest position. Asio Capital LLC’s holdings in HCA Healthcare were worth $7,056,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of HCA. CreativeOne Wealth LLC bought a new position in HCA Healthcare in the first quarter worth approximately $231,000. New Mexico Educational Retirement Board increased its position in shares of HCA Healthcare by 29.9% during the first quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock worth $4,636,000 after purchasing an additional 3,200 shares in the last quarter. Kingswood Wealth Advisors LLC acquired a new position in shares of HCA Healthcare during the first quarter worth $566,000. Teachers Retirement System of The State of Kentucky increased its position in shares of HCA Healthcare by 15.6% during the fourth quarter. Teachers Retirement System of The State of Kentucky now owns 199,209 shares of the company’s stock worth $53,922,000 after purchasing an additional 26,919 shares in the last quarter. Finally, Bessemer Group Inc. grew its holdings in shares of HCA Healthcare by 51.2% during the first quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock valued at $2,543,000 after buying an additional 2,584 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on HCA. Oppenheimer boosted their price objective on shares of HCA Healthcare from $345.00 to $390.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. StockNews.com raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. Deutsche Bank Aktiengesellschaft upped their price objective on shares of HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a research report on Friday, June 28th. Royal Bank of Canada upped their price objective on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research report on Friday, August 23rd. Finally, Barclays upped their price objective on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 24th. Five equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and four have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $365.65.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the sale, the senior vice president now owns 40,449 shares of the company’s stock, valued at $14,569,729.80. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the sale, the senior vice president now owns 9,454 shares of the company’s stock, valued at $3,436,623.54. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction on Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the completion of the sale, the senior vice president now directly owns 40,449 shares of the company’s stock, valued at $14,569,729.80. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 17,202 shares of company stock valued at $6,407,273 over the last quarter. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $394.54 on Friday. The company’s 50 day moving average is $387.15 and its two-hundred day moving average is $347.49. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $409.42. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The firm has a market cap of $103.34 billion, a PE ratio of 19.67, a price-to-earnings-growth ratio of 1.44 and a beta of 1.67.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The firm had revenue of $17.49 billion during the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. HCA Healthcare’s quarterly revenue was up 10.3% compared to the same quarter last year. During the same period in the previous year, the company earned $4.29 earnings per share. On average, research analysts expect that HCA Healthcare, Inc. will post 22.51 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, September 30th. Shareholders of record on Monday, September 16th were given a dividend of $0.66 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $2.64 annualized dividend and a yield of 0.67%. HCA Healthcare’s payout ratio is currently 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.